v3 Template
H

Holoclara

Biotechnology / Healthcare ~540 employees
Founded
--
Employees (Est.)
~540
27 leaders known
Total Funding
$16.0M
Funding Rounds
1
Last Funding
2024-06-27

About Holoclara

Holoclara is focused on transforming human health and aging by developing novel therapeutics derived from symbiotic organisms, specifically intestinal worms. Their mission is to restore missing components of the human molecular legacy disrupted by the removal of these organisms, addressing chronic diseases, inflammation, metabolism, and tissue regeneration without reintroducing live worms.

Products & Services

Therapeutics from Symbiotic Organisms:Drugs developed from organisms like intestinal worms that modulate inflammation, metabolism, and tissue regeneration to address chronic diseases and aging.

Specialties

Therapeutics from symbiotic organisms Immunomodulation Chronic disease treatment Aging and tissue regeneration Gut biome restoration Autoimmune disease therapy

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series A
T: -
FT: Series A
A: 16000000
MR: -
FA: $16 million
FAN: 16000000
D: 2024-06-27
FD: 2024-06-27
6 investors
Series A Latest
2024-06-27
$16.0M
6 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

A

ANDREA CHOE

CEO / CO-FOUNDER

LinkedIn (Pro only)
B

BRIAN VARNUM

HEAD OF RESEARCH & DEVELOPMENT

LinkedIn (Pro only)
H

HUNG NGUYEN

VP PRECLINICAL DEVELOPMENT

LinkedIn (Pro only)
O

OLIVER LOSÓN

VP BUSINESS OPERATIONS

M

MARIANA UCHOA

DIRECTOR OF IMMUNOLOGY

N

NICK EVERETTS

COMPUTATIONAL BIOLOGIST

View 24 more team members with Pro

Unlock Full Team Directory

Recent News

Holoclara Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Healthcare
Company Size
~540 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro